Information Provided By: 
Fly News Breaks for December 17, 2018
MMSI
Dec 17, 2018 | 13:06 EDT
Piper Jaffray analyst Matt O'Brien views Merit Medical Systems' acquisition of Vascular Insights as "another prudent solid tuck-in" for the company. Vascular's assets, used for the treatment of varicose veins, complement an "already substantial" vascular portfolio and should allows Merit's "large global salesforce" to address this $700M global market, O'Brien tells investors in a research note. He reiterates an Overweight rating on the shares with a $75 price target.
News For MMSI From the Last 2 Days
There are no results for your query MMSI
